–
Jasper Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY24 to FY25
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
−34.3
FY25:
−41.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−36.8
FY22:
−51.2
FY23:
−68.9
FY24:
−111
FY25:
−126
(positive)
Change from FY21 to FY25
millions USD
FY21:
−42.7
FY22:
−63.1
FY23:
−67.2
FY24:
−74.9
FY25:
−91.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.6
FY22:
−37.7
FY23:
−64.5
FY24:
−71.3
FY25:
−75.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.6
FY22:
−37.7
FY23:
−64.5
FY24:
−71.3
FY25:
−75.8
All amounts in millions USD